REGENXBIO Inc. (NASDAQ:RGNX) Q1 2026 Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q1 2026 Earnings Call Transcript May 14, 2026

REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.72 EPS, expectations were $-1.36.

Operator: Welcome, everyone, to the REGENXBIO RGX-2026 Top line Pivotal Data Webcast. At this time, I’d like to turn the conference over to Patrick Christmas, Chief Legal Officer of REGENXBIO. Please go ahead.

Patrick Christmas: Good morning, and thank you for joining us today. Earlier this morning, REGENXBIO released...